Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03245320 · ClinicalTrials.gov registry record
Clinical Evaluation of the TITAN™ Total Shoulder System
A clinical trial, sponsored by Smith & Nephew.
- Terminated
- Registry status
- 50
- Enrollment target
NCT03245320 is a clinical trial that was terminated before completion, run by Smith & Nephew. The registered enrollment target is 50 participants.
The verdict
NCT03245320 was terminated before completion, sponsored by Smith & Nephew.
- TERMINATED
- Registry status
- 50 participants
- Enrollment target
Study Summary
A post market, non-randomized, multi-center, open-label,clinical study using survivorship to study the safety and efficacy of the Integra® TITAN™ Total Shoulder System 1.0 (TAS) when used for total shoulder arthroplasty.
Interventions
- DEVICE Integra TITAN™ Total Shoulder Generation 1.0
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-03-20 |
| Est. Completion | 2022-06-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03245320
The ClinicalTrials.gov registry entry for NCT03245320 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Smith & Nephew, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Integra TITAN™ Total Shoulder Generation 1.0 is the first listed.
NCT03245320 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03245320 about?
NCT03245320 is a clinical study titled "Clinical Evaluation of the TITAN™ Total Shoulder System". A post market, non-randomized, multi-center, open-label,clinical study using survivorship to study the safety and efficacy of the Integra® TITAN™ Total Shoulder System 1.0 (TAS) when used for total shoulder arthroplasty.
What is the current status of trial NCT03245320?
This trial is currently terminated. The enrollment target is 50 participants. The study started on 2017-03-20. Estimated completion is 2022-06-23.
What interventions are being tested in trial NCT03245320?
The interventions under investigation include: Integra TITAN™ Total Shoulder Generation 1.0 (DEVICE).
Who is sponsoring clinical trial NCT03245320?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.